METRODEC, NCT04867109: HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding |
|
|
| Recruiting | N/A | 100 | Europe | Patients with Post menopausal bleeding, CA125 and HE4 assays | Nantes University Hospital, Roche Diagnostics | Endometrial Neoplasms, Postmenopause, Uterine Hemorrhage, Cancer Biomarker, CA 125 Antigen | 08/22 | 09/22 | | |